Affiliation: Cleveland Clinic Foundation
- Targeting the adrenal gland in castration-resistant prostate cancer: a case for orteronel, a selective CYP-17 17,20-lyase inhibitorHui Zhu
Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH 44195, USA
Curr Oncol Rep 15:105-12. 2013..Ongoing studies evaluating orteronel in CRPC will further define its safety and role in the management of this disease...